NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 5 நாட்களுக்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
SRPL Reports Q2 Loss of ₹15.25 Cr; Secured Assets Auctioned by Lender for ₹20.58 Cr
Shree Ram Proteins reported zero revenue from operations and a net loss of ₹15.25 crore for Q2 FY27 (quarter ended September 30, 2026), compared to a loss of ₹4.97 crore in Q2 FY26. Total income of ₹15.06 crore was driven entirely by a net gain on sale of assets following SARFAESI action by Union Bank of India, which auctioned plant, machinery, land, and buildings for ₹20.58 crore. The company took an exceptional inventory write-off of ₹11.18 crore and wrote off ₹24.26 crore of supplier advances during H1. The board re-appointed CMD Lalitkumar Vasoya for three years starting July 2027 and approved M/s H. Jamnadas & Co. as new statutory auditors.
உச்சம் நம்பிக்கை
என்ன மாறியதுLenders auctioned off the company's core production assets (plant, machinery, and land) under SARFAESI, and massive write-offs were taken on unrecoverable supplier advances and inventory.
ஏன் இது முக்கியம்The sale of factory land, building, and machinery strips the company of its core manufacturing capability, severely threatening its status as a going concern.
Revenue from operations (Q2): ₹0.00Net Loss (Q2): ₹1,524.75 லட்சம்SARFAESI Asset Auction Realization: ₹2,058.30 லட்சம்Auction proceeds vs Market Cap: ~206%Supplier advances written off (H1): ₹2,426.01 லட்சம்Inventory written off (Q2): ₹1,118.36 லட்சம்
📅 குறுகிய காலம்Negative sentiment will likely persist as financial results confirm severe operational distress, default on loans, and enforcement of security by lenders.
📈 நீண்ட காலம்With the auction of primary operating assets and zero ongoing operational revenue, the company faces existential solvency and going-concern challenges.
⚠ அபாய எச்சரிக்கைகள்
Loss of primary manufacturing assets via bank auction
Default on bank loan covenants and statutory dues
Large-scale write-offs of inventories (₹11.18 cr) and supplier advances (₹24.26 cr)
Severe liquidity shortage and persistent zero operational revenue
👀 கவனிக்க வேண்டியவை
Track the company's remaining debt obligations and whether any operational activities can continue following the liquidation of its core plant, machinery, and factory premises by lenders.
SRPL Sells Immovable Property for ₹16.76 Cr to KSP Auto and Forge
Shree Ram Proteins Limited (SRPL) has completed the sale of its immovable property located at Gondal, Rajkot, Gujarat for a consideration of ₹16.76 crore on September 21, 2026. The buyer is KSP Auto and Forge Private Limited, an unrelated third party. The transaction represents a substantial liquidity event for SRPL, whose current market capitalization is approximately ₹10 crore against total debt of ₹37 crore. The sale follows shareholder approval secured via postal ballot on September 9, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுSRPL completed the monetization and sale deed execution of its land property in Gondal, Rajkot for ₹16.76 crore.
ஏன் இது முக்கியம்The ₹16.76 crore proceeds exceed the company's current market cap of ₹10 crore, offering critical liquidity to a distressed business that generated ₹0 TTM revenue and holds ₹37 crore in debt.
Sale consideration: Rs. 16,76,30000/-Sale value vs Market Cap: ~167%Completion date: செப்டம்பர் 21, 2026Postal ballot approval date: செப்டம்பர் 9, 2026
📅 குறுகிய காலம்Provides immediate liquidity relief, which may help address near-term default risks and statutory obligations.
📈 நீண்ட காலம்While asset sales ease immediate insolvency pressure, core solvent extraction operations remain stalled with zero revenue across recent quarters.
⚠ அபாய எச்சரிக்கைகள்
Core operations remain inactive (₹0 revenue)
Significant outstanding debt burden of ₹37 Cr
Asset disposal reduces the fixed asset base of the company
👀 கவனிக்க வேண்டியவை
Monitor upcoming quarterly filings to see whether proceeds are deployed toward debt reduction (total debt ₹37 Cr) or settlement of statutory dues.
SRPL Reports Q1 FY27 Net Loss of ₹6.36 Cr on Nil Operational Revenue; OTS Default Disclosed
Shree Ram Proteins Limited reported zero revenue from operations for the quarter ended June 30, 2026, alongside a net loss of ₹6.36 crore (compared to a loss of ₹1.82 crore in Q1 FY26). The company disclosed severe financial distress, noting it failed to pay the second OTS installment of ₹3.76 crore and the final installment of ₹18.56 crore to Union Bank of India after paying ₹2.43 crore upfront. Additionally, the bank sold secured assets worth ₹3.82 crore on May 18, 2026, reflecting severe working capital and liquidity shortfalls against an existing total debt burden of ₹37 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுSRPL approved Q1 FY27 unaudited results and FY26 audited results, revealing ongoing operational paralysis and failure to honor its bank OTS plan.
ஏன் இது முக்கியம்With zero revenue, negative net worth erosion, and a defaulted OTS, the company faces material uncertainty regarding its ability to continue as a going concern.
Q1 FY27 Revenue from Operations: ₹NilQ1 FY27 Net Loss: ₹6.36 கோடிDefaulted OTS 2nd Installment: ₹3.76 கோடிDefaulted OTS Final Installment: ₹18.56 கோடிLender Asset Sale Value: ₹3.82 கோடி
📅 குறுகிய காலம்Negative sentiment is likely to persist given the zero top-line, widening quarterly losses, and lender asset enforcement actions.
📈 நீண்ட காலம்High insolvency risk; operations cannot restart without resolving working capital deficits, statutory dues, and secured debt settlements.
⚠ அபாய எச்சரிக்கைகள்
Default on One-Time Settlement (OTS) with Union Bank of India
Material uncertainty over going concern status
Lender enforcement and liquidation of secured assets
Persistent zero operational revenue and depleted liquidity
👀 கவனிக்க வேண்டியவை
Track lender recovery actions or insolvency proceedings by Union Bank of India and monitor whether any preferential issue is approved to inject liquidity.
SRPL Reports Q1 FY27 Net Loss of ₹6.36 Cr on Zero Operational Revenue; OTS Defaults Persist
Shree Ram Proteins reported zero revenue from operations for the quarter ended June 30, 2026, consistent with prior quarters of halted business activity. The company recorded a net loss of ₹6.36 crore for the quarter, driven primarily by finance costs of ₹7.21 crore. Notes to the financial results disclose a critical default on a One-Time Settlement (OTS) with Union Bank of India, having failed to pay instalments of ₹3.76 crore and ₹18.56 crore. Furthermore, the bank sold assets/security worth ₹3.82 crore in May 2026, underlining acute insolvency and going-concern risks.
உச்சம் நம்பிக்கை
என்ன மாறியதுSRPL disclosed its audited FY26 and unaudited Q1 FY27 financial results, reporting continued zero operating revenue alongside default disclosures on its bank loan settlement.
ஏன் இது முக்கியம்The company has an unserviced debt burden (₹37 crore) relative to its market cap of ₹10 crore, with defaulted OTS terms and asset sales signaling extreme insolvency risk.
Q1 FY27 Revenue from Operations: ₹0.00Q1 FY27 Net Loss: ₹6.36 கோடிFinance Costs (Q1 FY27): ₹7.21 கோடிDefaulted OTS Final Instalment: ₹18.56 கோடிDefaulted Debt vs Market Cap: ~185% of Market Cap (₹18.56 Cr / ₹10 Cr)
📅 குறுகிய காலம்Negative sentiment is likely to persist as operational shutdown continues and lenders exercise legal recovery actions.
📈 நீண்ட காலம்Going-concern viability remains in severe doubt without a massive capital infusion or formal debt restructuring.
⚠ அபாய எச்சரிக்கைகள்
Going-concern risk flagged by auditors
Default on Union Bank of India OTS instalments totaling over ₹22 crore
Zero operational revenue indicating halted plant operations
👀 கவனிக்க வேண்டியவை
Track lender recovery proceedings and potential insolvency resolution or liquidation steps by Union Bank of India given the defaulted OTS terms.
SRPL Shareholders Approve Disposal of Whole or Substantially Whole of Company Undertaking
Shree Ram Proteins Limited has submitted voting results and a scrutinizer's report for a postal ballot approving a Special Resolution under Section 180(1)(a) of the Companies Act, 2013, to sell, lease, or otherwise dispose of the whole or substantially the whole of the undertaking of the company. A total of 17,675,333 votes were cast, with 17,656,004 votes (99.89%) in favor and 19,329 votes against. The approval comes as the distressed company posted zero TTM revenue and holds Rs 37 Cr in debt against a market capitalization of Rs 10 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுShareholders have formally approved the enabling resolution granting the Board authority to sell, lease, or dispose of the whole or substantially the whole of the company's undertaking.
ஏன் இது முக்கியம்With TTM revenue at Rs 0 Cr, continuous quarterly net losses, and Rs 37 Cr in debt, monetizing or selling the undertaking is a critical restructuring or survival move for the company.
Total valid votes polled: 17675333Votes in favour (%): 99.8906%Votes against (%): 0.1094%Debt vs Market Cap: 3.7x (Rs 37 Cr debt / Rs 10 Cr m-cap)
📅 குறுகிய காலம்Markets will watch for execution announcements detailing what specific plant, assets, or undertaking are being disposed of and whether proceeds will clear outstanding dues.
📈 நீண்ட காலம்Disposing of the core undertaking may lead to corporate restructuring, total change in business activity, or liquidation given prolonged lack of operational revenue.
⚠ அபாய எச்சரிக்கைகள்
Complete disposal of primary operational assets or business undertaking
Extreme financial distress with zero revenue and negative net worth erosion
Low promoter holding of 4.08%
👀 கவனிக்க வேண்டியவை
Track subsequent exchange filings for the exact transaction details, buyer identity, asset valuation, and terms regarding the proposed sale or lease of the company's undertaking.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
SRPL Shareholders Approve Sale of Undertaking and Capital Raise via QIP
Shree Ram Proteins Limited has submitted a revised scrutinizer report for its EOGM held on March 05, 2026. Shareholders approved Resolution 1 for the sale of the company's undertaking as a material related party transaction, with 7,714,361 valid votes in favour (100% of valid votes) and 8,733,679 invalid votes. Shareholders also approved Resolution 2 to raise capital via Qualified Institutions Placement (QIP) with 16,433,040 votes in favour and 15,000 against. The company is facing severe distress with zero TTM revenue, Rs 37 Cr in debt, and a market capitalization of Rs 10 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுShareholders formally approved the sale of the company's operating undertaking as a material related-party transaction and authorized equity capital raising via QIP.
ஏன் இது முக்கியம்With TTM revenue at Rs 0 Cr, negative net worth trajectory, and Rs 37 Cr debt, selling assets and raising QIP capital are critical survival and debt-restructuring measures.
Votes in favour (Sale of undertaking): 7714361 votesInvalid votes (Sale of undertaking): 8733679 votesVotes in favour (QIP raise): 16433040 votesVotes against (QIP raise): 15000 votesசந்தை மதிப்பு: Rs 10 கோடிTotal Debt: Rs 37 கோடி
📅 குறுகிய காலம்Scrutinizer report confirmation removes procedural uncertainty around shareholder assent, but disclosures on transaction execution and QIP pricing remain pending.
📈 நீண்ட காலம்The sale of the undertaking indicates an exit or structural downsizing of current manufacturing operations, while any QIP could cause heavy dilution for a micro-cap with a 4.08% promoter stake.
⚠ அபாய எச்சரிக்கைகள்
Related-party transaction risk regarding valuation and transfer terms in the sale of the undertaking.
Significant potential equity dilution from QIP given the low market cap of Rs 10 Cr.
Large block of invalid votes (8.73M votes) on the asset sale resolution.
👀 கவனிக்க வேண்டியவை
Track subsequent exchange disclosures regarding the exact valuation and buyer details for the undertaking sale, along with the issue price and dilution quantum for the proposed QIP.
SRPL Posts ₹6.36 Cr Q1 Loss; Plant Auctioned at ₹3.82 Cr Post Debt Default
Shree Ram Proteins reported zero revenue from operations for both Q1 FY27 (quarter ended June 30, 2026) and the full year FY26. Net loss for Q1 FY27 widened to ₹6.36 Cr (compared to ₹1.82 Cr in Q1 FY26), heavily impacted by finance costs of ₹7.21 Cr. The company defaulted on its One-Time Settlement (OTS) with Union Bank of India after missing scheduled installments of ₹3.76 Cr and ₹18.56 Cr. Consequently, the lender auctioned the company's plant and machinery on May 18, 2026 for ₹3.82 Cr, leading the statutory auditors to issue an adverse opinion with material going-concern uncertainty.
உச்சம் நம்பிக்கை
என்ன மாறியதுReported audited FY26 and unaudited Q1 FY27 financials showing zero revenue, while disclosing the bank-forced auction of its plant and machinery.
ஏன் இது முக்கியம்The auction of key manufacturing assets and persistent OTS defaults severely jeopardize operational viability, placing the company's going-concern status under extreme risk.
Revenue from Operations (Q1 FY27): ₹0.00Net Loss (Q1 FY27): ₹636.40 லட்சம்Net Loss (FY26): ₹1,010.85 லட்சம்Overdue OTS Installments: ₹2,232.50 லட்சம்Plant & Machinery Auction Value: ₹382.00 Lakh
📅 குறுகிய காலம்Negative sentiment is likely to persist given the adverse audit report, asset liquidation by lenders, and lack of core revenue generation.
📈 நீண்ட காலம்Severe survival risk; core manufacturing operations are halted following the auction of plant and machinery unless substantial recapitalization occurs.
⚠ அபாய எச்சரிக்கைகள்
Going concern uncertainty with adverse auditor opinion
Auction of entire plant and machinery by secured lender
Default on One-Time Settlement (OTS) and loan covenants
Zero operational revenue
👀 கவனிக்க வேண்டியவை
Track lender recovery actions, potential insolvency (IBC) proceedings, and corporate disclosures regarding debt restructuring or capital raising.
SRPL Reports Q1 Loss of ₹6.36 Cr with Zero Operations; Bank Auctions Entire Plant & Machinery
Shree Ram Proteins reported a standalone net loss of ₹6.36 Cr for the quarter ended June 30, 2026, widening from a loss of ₹1.82 Cr in the year-ago period, with zero revenue from operations. Total expenses stood at ₹7.76 Cr, primarily driven by finance costs of ₹7.21 Cr. The company disclosed that it failed to honor its One-Time Settlement (OTS) terms with Union Bank of India, defaulting on installments of ₹3.76 Cr and ₹18.56 Cr after an initial upfront payment of ₹2.43 Cr. Furthermore, the statutory auditors issued an adverse opinion, highlighting that the lender auctioned the entire plant and machinery on May 18, 2026, for ₹3.82 Cr, creating severe going-concern risk.
உச்சம் நம்பிக்கை
என்ன மாறியதுSRPL posted another quarter of zero operational revenue while confirming that its main manufacturing assets were auctioned off by its secured lender following an OTS default.
ஏன் இது முக்கியம்The auction of all plant and machinery and acute liquidity distress indicate a halt in core processing activities and heightened risk of insolvency.
Net Loss (Q1 ended Jun 2026): ₹6.36 கோடிRevenue from Operations: ₹0.00Plant & Machinery Auction Realization: ₹3.82 கோடிDefaulted OTS Installments: ₹22.33 கோடிFinance Costs (Q1): ₹7.21 கோடி
📅 குறுகிய காலம்Negative outlook expected due to the adverse auditor opinion, operational shutdown, and unresolved defaults.
📈 நீண்ட காலம்Viability as a going concern is critically impaired following the disposal of core productive assets and heavy debt burden.
⚠ அபாய எச்சரிக்கைகள்
Loss of primary manufacturing assets via bank auction
Default on bank loan OTS and statutory dues
Adverse audit conclusion and material uncertainty on going concern
Zero operational revenue
👀 கவனிக்க வேண்டியவை
Track further regulatory filings regarding legal or insolvency proceedings, potential debt resolution steps, and any plans for equity restructuring.
₹17 Cr Asset Sale: SRPL Seeks Shareholder Approval to Sell Main Undertaking
Shree Ram Proteins Limited (SRPL) has issued a postal ballot notice seeking shareholder approval to sell its primary undertaking, including land and machinery at Rajkot, for approximately ₹17 crore. This transaction is critical as the company currently reports zero TTM revenue and carries a debt of ₹37 crore. The proposed sale value of ₹17 crore represents roughly 121% of the company's current market capitalization of ₹14 crore. Proceeds are intended for debt repayment and working capital to address the company's severe liquidity crunch.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company is re-attempting to sell its core manufacturing asset after a previous transaction failed, now seeking a broader mandate to sell to unidentified purchasers.
ஏன் இது முக்கியம்For a company with zero revenue and a default rating, this asset sale is a survival necessity to settle outstanding loans and potentially restart operations.
Proposed sale value: ₹17.00 கோடிSale value vs Market Cap: ~121%Total Debt: ₹37 கோடிTTM வருவாய்: ₹0 கோடிPromoter Holding: 4.08%
📅 குறுகிய காலம்The stock may experience volatility during the 30-day voting period as the market assesses the likelihood of a successful debt reduction.
📈 நீண்ட காலம்Highly uncertain; while the sale reduces debt, it involves disposing of the 'whole or substantially the whole' of the company's undertaking, leaving the future business model unclear.
⚠ அபாய எச்சரிக்கைகள்
Extremely low promoter holding (4.08%)
History of failed asset sale execution
Disposal of core manufacturing assets
High debt-to-equity ratio of 2.06
👀 கவனிக்க வேண்டியவை
Investors should monitor the e-voting results due by September 11, 2026, and watch for the identification of the final purchaser and the actual realization of sale proceeds.
Rs 17 Cr Sale of Undertaking Approved by Shree Ram Proteins Board
The Board of Shree Ram Proteins (SRPL) has approved the sale of its entire undertaking for an aggregate consideration of approximately Rs 17.00 crore. This move is significant as the company currently has a market capitalization of just Rs 14 crore and a total debt of Rs 37 crore. The company has reported zero revenue for the last four quarters and is in severe financial distress with a default rating. The sale is subject to shareholder approval via postal ballot and regulatory clearances.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned from seeking survival through preferential issues to proposing a sale of its primary business undertaking.
ஏன் இது முக்கியம்This is a critical event for a company in default; the sale price is higher than the current market value but insufficient to cover total debt, suggesting significant remaining financial risk for equity holders.
Sale Consideration: Rs 17.00 Croreசந்தை மதிப்பு: Rs 14 CroreTotal Debt: Rs 37 CroreSale Value vs Market Cap: 121.4%Sale Value vs Total Debt: 45.9%
📅 குறுகிய காலம்The stock may see volatility as the market digests the Rs 17 crore valuation against the Rs 14 crore market cap, though the underlying debt crisis remains unresolved.
📈 நீண்ட காலம்The long-term outlook is highly uncertain as the company is selling its core undertaking; it effectively signals an exit from current operations to settle a portion of its liabilities.
⚠ அபாய எச்சரிக்கைகள்
Proceeds (Rs 17 Cr) are significantly lower than total debt (Rs 37 Cr)
Extremely low promoter holding of 4.08%
Operational halt with zero revenue for over a year
Default rating (IVR D) and liquidity crunch
👀 கவனிக்க வேண்டியவை
Investors should monitor the Postal Ballot results and subsequent disclosures regarding the identity of the buyer and the specific plan for debt repayment. The primary concern remains whether the Rs 17 crore proceeds will be sufficient to prevent liquidation given the Rs 37 crore debt burden.
SRPL Faces Adverse Audit Opinion and Insolvency Proceedings for FY25
Shree Ram Proteins Limited (SRPL) has received an 'Adverse Opinion' from its auditors for the financial year ended March 31, 2025, indicating the financial statements do not provide a true and fair view. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the IBC 2016 due to defaults on loans and statutory dues. Financial performance has collapsed, with FY25 revenue at Rs 0.0 Cr and a net loss of Rs 21.08 Cr. Auditors highlighted a total lack of physical verification for inventories and fixed assets, alongside missing balance confirmations for debtors and creditors.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company provided a formal response to NSE's clarification request, confirming that its auditors have issued an adverse opinion and that the company is officially in insolvency proceedings.
ஏன் இது முக்கியம்This confirms the company is in severe financial distress with no operational revenue and is unable to meet its debt obligations of Rs 37 Cr, placing the equity at risk of total loss in a restructuring or liquidation scenario.
FY25 Revenue: Rs 0.0 கோடிFY25 Net Loss: Rs -21.08 crTotal Debt: Rs 37 கோடிDebt to Market Cap Ratio: 2.64xPromoter Holding: 4.08%
📅 குறுகிய காலம்The stock is likely to remain under extreme pressure or face trading restrictions due to the adverse audit opinion and ongoing insolvency proceedings.
📈 நீண்ட காலம்The long-term outlook is highly uncertain and depends entirely on the outcome of the CIRP; typical outcomes in such cases involve significant equity dilution or liquidation.
⚠ அபாய எச்சரிக்கைகள்
Insolvency proceedings (CIRP)
Adverse Audit Opinion
Zero operational revenue
Default on loans and statutory dues
Extremely low promoter holding
👀 கவனிக்க வேண்டியவை
Investors should closely monitor NCLT updates regarding the Corporate Insolvency Resolution Process (CIRP) as the company faces a high risk of liquidation. The adverse audit opinion suggests that the reported financial figures may not be reliable for valuation purposes.
SRPL Submits Pending Annual Reports for FY24 & FY25; Requests Revocation of Trading Suspension
Shree Ram Proteins Limited (SRPL) has completed the submission of its Annual Reports for two consecutive financial years, FY 2023-24 and FY 2024-25, via the NEAPS portal on February 11, 2026. This action follows a suspension notice from the NSE dated December 30, 2025, triggered by non-compliance with Regulation 34 of SEBI (LODR) Regulations. The company is also filing a compounding petition under Section 441 of the Companies Act for delays in holding its Annual General Meetings. SRPL has formally requested the exchange to revoke the suspension of trading in its securities following these filings.
முக்கிய அம்சங்கள்
Submitted pending Annual Reports for FY 2023-24 and FY 2024-25 on February 11, 2026Addressed NSE suspension notice (Ref: NSE/LIST/C/2025/13391) regarding non-complianceInitiated compounding petition under Section 441 for delays in holding AGMs for the specified yearsFormally requested NSE to revoke the suspension of trading in the company's securities
👀 கவனிக்க வேண்டியவை
Investors should wait for official confirmation from the NSE regarding the revocation of the trading suspension before making any decisions. The history of significant compliance delays and the need for legal compounding suggest a high-risk profile for this stock.
Shree Ram Proteins to Sell Land Undertaking for ₹30 Crore to Sova Agrotech
Shree Ram Proteins Limited (SRPL) has received shareholder approval to sell its land undertaking in Gondal, Rajkot, for a total consideration not exceeding ₹30 Crore. The sale is being made to Sova Agrotech Private Limited, a related party, with the transaction expected to be completed by April 2026. The company aims to use the proceeds to streamline its asset base, reduce maintenance costs, and focus on core business operations. The disposal was approved via a special resolution during the Extra Ordinary General Meeting held on March 5, 2026.
முக்கிய அம்சங்கள்
Sale of land situated at Gondal, Rajkot for a consideration of up to ₹30 Crore.Transaction is with Sova Agrotech Private Limited, a related party involving promoter Ms. Geetaben Lalitbhai Vasoya.Expected completion date for the sale/disposal is set for April 2026.Shareholder approval obtained via special resolution at the EGM held on March 5, 2026.Strategic rationale includes streamlining assets and focusing on core business operations.
👀 கவனிக்க வேண்டியவை
Investors should track the actual receipt of the ₹30 Crore and how the management redeploys this capital into core operations. Given it is a related party transaction, verify that the final valuation aligns with independent market benchmarks.
Shree Ram Proteins Shareholders Approve Asset Sale and QIP Capital Raise
Shree Ram Proteins Limited (SRPL) has received shareholder approval for two critical resolutions during its EOGM held on March 05, 2026. The first resolution, involving the sale of a company undertaking as a material related party transaction, passed with 100% of the 16,448,040 votes in favor. The second resolution authorizes the company to raise capital through a Qualified Institutions Placement (QIP), which was approved by a 99.91% majority. These approvals provide the company with the mandate to restructure its assets and seek fresh institutional investment.
முக்கிய அம்சங்கள்
100% shareholder approval for the sale of a company undertaking as a material related party transaction involving 16,448,040 votes.99.91% majority (16,436,640 votes) in favor of raising capital via Qualified Institutions Placement (QIP).Total of 54 members participated in the electronic voting process representing 16,448,040 shares.The QIP resolution saw minimal opposition, with only 15,000 votes (0.09%) cast against it.
👀 கவனிக்க வேண்டியவை
Investors should monitor the pricing and dilution impact of the upcoming QIP and the specific terms of the asset sale. The high approval rate suggests strong alignment between participating shareholders and management's strategic restructuring plans.
Shree Ram Proteins Reports Zero Revenue and ₹21.07 Cr Net Loss in FY25; Issues AGM Addendum
Shree Ram Proteins Limited (SRPL) has issued a corrigendum and addendum to its 17th Annual Report and AGM notice, primarily to include the missing Secretarial Audit Report and correct director re-appointment details. The company's financial health has deteriorated severely, with revenue from operations falling to zero in FY 2024-25 compared to ₹1,476.60 Lakhs in the previous year. Net loss has more than doubled to ₹2,107.51 Lakhs, driven by the total halt in operations. The company is currently attempting to raise up to ₹49 Crores through a Rights Issue to stabilize its position.
முக்கிய அம்சங்கள்
Revenue from operations dropped 100% to zero in FY 2024-25 from ₹1,476.60 Lakhs in FY 2023-24.Net loss widened significantly to ₹2,107.51 Lakhs for the year ended March 31, 2025.Corrigendum issued to correct the director retiring by rotation from Mr. Ravindra Kumar Singh to Mr. Piyush Vasoya.Secretarial Audit Report for FY 2024-25 (pages 71-91) added as an addendum to the Annual Report.Company is pursuing a Rights Issue of up to ₹49 Crores and a preferential allotment of 5 crore shares.
👀 கவனிக்க வேண்டியவை
Investors should be highly concerned by the total cessation of operational revenue and the widening losses; the stock remains a high-risk speculative play contingent on the success of the proposed fundraise.
Shree Ram Proteins Reports Cessation of 3 Independent Directors Due to Delayed AGM
Shree Ram Proteins Limited (SRPL) has announced the cessation of three Additional Independent Directors effective February 5, 2026. The directors, Ms. Naaz Jaiswal, Mr. Akash Sureshbhai Gajera, and Mr. Yogeshbhaichandubhai Dhanani, have vacated their offices due to the company's failure to hold its Annual General Meeting (AGM) within the statutory due date. This automatic cessation is mandated under Section 161(1) of the Companies Act, 2013, which requires additional directors to step down on the date the AGM should have been held. This development highlights a significant lapse in corporate governance and regulatory compliance.
முக்கிய அம்சங்கள்
Cessation of 3 Additional Independent Directors effective from February 5, 2026.Directors involved are Ms. Naaz Jaiswal, Mr. Akash Sureshbhai Gajera, and Mr. Yogeshbhaichandubhai Dhanani.The cessation resulted from the company's failure to conduct its Annual General Meeting (AGM) within the statutory timeline.Action taken in accordance with Section 161(1) of the Companies Act, 2013.The vacancy of three independent directors simultaneously may affect board composition and committee requirements.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the failure to hold an AGM on time is a red flag regarding internal controls and regulatory compliance. Monitor the company's next steps for appointing new directors and scheduling the overdue AGM.
SRPL to Raise ₹100 Cr and Acquire Stake in Sova Agrotech for ₹30 Cr
Shree Ram Proteins Limited (SRPL) has approved a major fundraising plan of up to ₹100 Crores through equity or convertible securities. A significant portion of these funds, up to ₹30 Crores, is designated for acquiring a controlling stake in Sova Agrotech Private Limited, which is currently settling debts with Union Bank. The company also approved the sale of its land in Rajkot and is undergoing a major board restructuring with four new director appointments. Notably, the company is clearing a backlog of compliance by scheduling its 15th and 16th AGMs simultaneously in March 2026.
முக்கிய அம்சங்கள்
Approved fundraising of up to ₹100 Crores via preferential issue, rights issue, or other equity-linked instruments.Proposed acquisition of a controlling stake in Sova Agrotech Private Limited for ₹30 Crores.Sova Agrotech to acquire land, plant, and machinery for ₹24.75 Crores via a One Time Settlement (OTS) with Union Bank of India.Approved the sale of company-owned land at Bhunava, Rajkot, subject to shareholder approval.Scheduled the 15th AGM (FY24), 16th AGM (FY25), and an EGM all for March 5, 2026, to address pending regulatory matters.
👀 கவனிக்க வேண்டியவை
Investors should be cautious as the company is holding AGMs for 2024 and 2025 in 2026, indicating significant past compliance delays. Monitor the specific terms of the ₹100 Crore fundraise and the valuation details of the Sova Agrotech acquisition before committing capital.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
